IFNLR1 and neoplasm: Hence, it is conceivable that within the tumor microenvironment, the concentrations of IFNLR1 are exquisitely controlled by FBXO45 such that the robustness of signaling events downstream of IFN-λ–receptor activation (JAK-STAT1) impacts tumorigenesis.